The quality of care for treatment of early stage breast carcinoma: Is it consistent with national guidelines?

Cancer

Volumn 83, Issue 2, 1998, Pages 302-309

  Guadagnoli, Edward ^a   Shapiro, Charles L ^b   Weeks, Jane C ^b   Gurwitz, Jerry H ^c   Borbas, Catherine ^d   Soumerai, Stephen B ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d Hlthcare Educ Research Foundation   (United States)

^e HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

Adjuvant therapy; Axillary lymph node dissection; Early stage breast carcinoma; Health services research; Quality of care; Radiation therapy

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; EARLY DIAGNOSIS; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; LYMPH NODE EXCISION; MASSACHUSETTS; MIDDLE AGED; MINNESOTA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 0032527968     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980715)83:2<302::AID-CNCR14>3.0.CO;2-X     Document Type: Article

References (35)

1. National Institute of Health. National Institute of Health Consensus Development Conference Statement. The treatment of primary cancer: management of the local disease. June 5, 1979.
2. National Institute of Health. National Institutes of Health Consensus Development Conference Statement. Treatment of early stage breast cancer, June 18-21, 1990.
3. NIH Consensus - Development Statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus Development Panel. N Engl J Med 1980;303:831-2.
4. National Institute of Health. Adjuvant chemotherapy for breast cancer. JAMA 1985;254:3461-3.
5. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
6. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Part 2. Lancet 1992;339:71-85.
7. Glick JH, Gelber RD, Goldhirsch A, Senn J-H. Meeting highlights: adjuvant therapy for primary breast cancer. J Natl Cancer Inst 1992;84:1479-85.
8. Goldhirsch A, Wood WC, Senn H-J, Glick JH, Gelber RD. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995; 87:1441-5.
9. Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB. The use of breast-conserving surgery for treatment of early stage breast cancer. J Clin Oncol 1998;16: 101-6.
10. Lazovich D, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266: 3433-8.
11. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992;326:1102-7.
12. Nattinger AB, Gottlieb MS, Hoffman RG, Walker AP, Goodwin JS. Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care 1996;34:479-89.
13. Young WW, Marks SM, Kohler SA, Hsu AY. Dissemination of clinical results: mastectomy versus lumpectomy and radiation therapy. Med Care 1996;34:1003-17.
14. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326:1097-101.
15. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. JAMA 1994;271:1163-8.
16. Hand R, Sener S, Imperato J, Chmiel JS, Sylvester J, Fremgen A. Hospital variables associated with quality of care for breast cancer patients. JAMA 1991;266:3429-32.
17. Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996;335:791-9.
18. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;92:703-10.
19. American Hospital Association. The AHA guide to the health care field. Chicago: American Hospital Association, 1993.
20. Folio Associates, Inc. Folio's Medical Directory of Massachusetts. Boston: Folio Associates, Inc., 1993.
21. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257: 2766-70.
22. Hosmer DW, Lemeshow S. Applied logistic regression. Toronto: John Wiley & Sons, 1989.
23. Clark R, McCulloch P, Levine M, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84:683-9.
24. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
25. Liljegren G, Holmberg L, Adami H-O, Westman G, Graffman S, Bergh J. Sector resection with and without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 1994;86:717-22.
26. Fisher B, Redmond C. Lumpectomy for breast cancer: an update of the NSABP experience. Monogr Natl Cancer Inst 1992;11:7-13.
27. Nemoto T, Patel J, Rosner D, Daco TL, Schuh M, Penetrante R. Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 1991;67:2079-82.
28. Cady B, Stone M, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;183:338-47.
29. Lin P, Allison D, Wainstuck J, Miller KD, Dooley WC, Friedman N, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11: 1536-44.
30. Silverstein M, Gierson E, Waisman J, Gierson ED, Colburn WJ, Senofsky GM. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994;73:664-7.
31. Chadha M, Chabon A, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer 1994;73:350-3.
32. Ravdin P, DeLaurentis M, Wenger C, Clark GM. Can prognostic factors be used to predict the nodal status of breast cancer patients? Proc Am Soc Clin Oncol 1994;13:56.
33. Recht A, Pierce S, Abner A, Vicini F, Osteen RT, Lover SM, et al. Regional node failure after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol 1991;9:988-96.
34. Haffty B, McKhann C, Beinfield M, Fischer D, Fischer JJ. Breast conservation therapy without axillary node dissection. A rational treatment strategy in selected patients. Arch Surg 1993;128:1315-9.
35. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfleld SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-26.